More Company News

Q320 interim report
05 Nov 2020Read More

Q220 interim report
17 Jul 2020Read More

FORTIFY patient enrolment finalised earlier than original plan
15 Jun 2020Read More

Own sales organisation in the Netherlands
08 Jun 2020Read More

Completion of SEK 378m directed share issue
27 May 2020Read More

Q120 interim report
08 May 2020Read More

Appointment of General Manager and EVP Commercial Operations North America
29 Apr 2020Read More

De Novo application for CERAMENT G submitted to the FDA
17 Apr 2020Read More

Publication of 2019 Annual Report and COVID-19 commentary
03 Apr 2020Read More

Accelerated road to US market approval for CERAMENT G via De Novo application
23 Mar 2020Read More

1 2 3 4 5
© 2019-21 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).